Merck acted responsibly, from researching Vioxx prior to approval in studies with almost 10,000 patients, to monitoring the medicine while it was on the market, to voluntarily withdrawing the medicine when it did. We based our decisions on the data from well controlled clinical trials.
The company has always said that every case presents a different set of facts. We will make a reasonable decision in how to proceed in defending each case.